Literature DB >> 27795243

Complete Genome Sequence of the First H5N1 Avian Influenza Virus Isolated from Chickens in Lebanon in 2016.

Elias Ibrahim1, Abeer Sirawan1, Bassel El-Bazzal1, Jeanne El Hage2, Mounir Abi Said3, Hassan Zaraket4, Ahmed Kandeil5, Mohamed A Ali5, Ghazi Kayali6,7.   

Abstract

We generated the full genome of a highly pathogenic H5N1 avian influenza virus that caused an outbreak on a chicken farm in Lebnaon in April 2016. Analysis revealed that the virus belonged to clade 2.3.2.1c that recently caused outbreaks in West Africa and the United Arab Emirates.
Copyright © 2016 Ibrahim et al.

Entities:  

Year:  2016        PMID: 27795243      PMCID: PMC5073251          DOI: 10.1128/genomeA.01062-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Highly pathogenic avian influenza (HPAI) H5N1 viruses were first detected in 1997 (1). Then, they spread widely and evolved rapidly into 10 distinct clades (0 to 9). Clades 2.1.3.2, 2.2.1.2, 2.3.2.1, 2.3.4.4, and 7.2 were detected in 2014 and continue to circulate globally (2). Clade 2.2 viruses were first detected in the Middle East in 2005 causing sporadic outbreaks in several countries and becoming enzootic in Egypt (3). No outbreaks were detected in Lebanon until April 2016, when a chicken farm in the Beqaa region had high mortality with symptoms resembling HPAI infection. The Lebanese Ministry of Agriculture detected HPAI H5 infection and successfully controlled the outbreak through culling and monitoring of neighboring farms. An A/chicken/Lebanon/157/2016(H5N1) virus was isolated from infected chickens. Viral RNA was extracted using a QIAamp viral RNA minikit (Qiagen, Germany) according to the manufacturer’s protocol. The first-strand cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen, CA) and Uni-12 primer (5′ AGCRAAAGCAGG3′) per manufacturer’s protocol. Genes were amplified using the Phusion master mix kit (Thermo, MA) and universal primers (4). Amplified products were sequenced at Macrogen (Macrogen, South Korea) and were assembled using SeqMan (DNASTAR, WI). The eight genome segments encoded PB2, PB1, PB1-F2, PA, PA-X, HA, NP, NA, M1, M2, NS1, and NS2 viral proteins with lengths 759, 757, 57, 716, 252, 567, 498, 449, 252, 97, 225, and 121 amino acids (aa), respectively. The HA cleavage motif sequence of H5N1 isolates was RERRRKR*GLF, which is the signature of HPAI viruses. Analysis of the NXT/S motif (X can be any amino acid except proline) revealed that the isolate had seven potential glycosylation sites, at positions 10 (NNST), 23 (NVT), 140 (NSS), 165 (NNT), 286 (NSS), 483 (NGS), and 542 (NGS) (H5 numbering) within the HA molecule. The virus had Q222 and G224 at the receptor binding site, suggesting that it favors avian-like receptors (5). However, it also contained aa N and A at sites 94 and 133 instead of D and S, respectively, which is believed to enhance binding to α2-6 receptors (6). The analysis of the NA gene revealed a 20 aa deletion in the NA stalk region (positions 49 to 68). The virus had an NA substitution V149A that potentially reduced susceptibility to zanamivir (7). Mutations E627K and D701N in the PB2 that facilitate the adaptation of avian viruses to mammals, and increase transmission and/or pathogenicity (8, 9), were not recorded. The BLASTn and phylogenetic analysis of all eight segments revealed that the virus was closely related to the recent clade 2.3.2.1c viruses that circulated in West Africa (Ivory Coast, Niger, and Ghana) and India with high sequence homologies (98 to 99%). This clade has been previously detected in the United Arab Emirates in wild bird species (10). The emergence of this H5N1 clade in the Middle East is of both veterinary and human public health concern and requires surveillance at the human-animal interface.

Accession number(s).

The complete genome sequence of the A/chicken/Lebanon/157/2016(H5N1) virus was deposited in GenBank under the accession numbers KX644138 to KX644145.
  9 in total

1.  Outbreaks of highly pathogenic avian influenza H5N1 clade 2.3.2.1c in hunting falcons and kept wild birds in Dubai implicate intercontinental virus spread.

Authors:  Mahmoud M Naguib; Jörg Kinne; Honglin Chen; Kwok-Hung Chan; Sunitha Joseph; Po-Chun Wong; Patrick C Y Woo; Renate Wernery; Martin Beer; Ulrich Wernery; Timm C Harder
Journal:  J Gen Virol       Date:  2015-11       Impact factor: 3.891

2.  Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.

Authors:  M Naughtin; J C Dyason; S Mardy; S Sorn; M von Itzstein; P Buchy
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

4.  Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.

Authors:  K F Shortridge; N N Zhou; Y Guan; P Gao; T Ito; Y Kawaoka; S Kodihalli; S Krauss; D Markwell; K G Murti; M Norwood; D Senne; L Sims; A Takada; R G Webster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

5.  PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice.

Authors:  Kyoko Shinya; Stefan Hamm; Masato Hatta; Hiroshi Ito; Toshihiro Ito; Yoshihiro Kawaoka
Journal:  Virology       Date:  2004-03-15       Impact factor: 3.616

6.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Authors:  Shinya Yamada; Yasuo Suzuki; Takashi Suzuki; Mai Q Le; Chairul A Nidom; Yuko Sakai-Tagawa; Yukiko Muramoto; Mutsumi Ito; Maki Kiso; Taisuke Horimoto; Kyoko Shinya; Toshihiko Sawada; Makoto Kiso; Taiichi Usui; Takeomi Murata; Yipu Lin; Alan Hay; Lesley F Haire; David J Stevens; Rupert J Russell; Steven J Gamblin; John J Skehel; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-11-16       Impact factor: 49.962

7.  Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014.

Authors:  Gavin J D Smith; Ruben O Donis
Journal:  Influenza Other Respir Viruses       Date:  2015-09       Impact factor: 4.380

8.  Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host.

Authors:  Yuwei Gao; Ying Zhang; Kyoko Shinya; Guohua Deng; Yongping Jiang; Zejun Li; Yuntao Guan; Guobin Tian; Yanbing Li; Jianzhong Shi; Liling Liu; Xianying Zeng; Zhigao Bu; Xianzhu Xia; Yoshihiro Kawaoka; Hualan Chen
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

9.  A single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles.

Authors:  Dong-Jiang Tang; Yuen-Man Lam; Yu-Lam Siu; Chi-Hong Lam; Shui-Ling Chu; J S Malik Peiris; Philippe Buchy; Béatrice Nal; Roberto Bruzzone
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

  9 in total
  4 in total

Review 1.  Certainty of success: three critical parameters in coronavirus vaccine development.

Authors:  David C Kaslow
Journal:  NPJ Vaccines       Date:  2020-05-25       Impact factor: 7.344

2.  Full sequence analysis of hemagglutinin and neuraminidase genes and proteins of highly pathogenic avian influenza H5N1 virus detected in Iran, 2015.

Authors:  Sima Yegani; Abdel-Hamid Shoushtari; Fatemeh Eshratabadi; Aidin Molouki
Journal:  Trop Anim Health Prod       Date:  2018-10-27       Impact factor: 1.559

3.  The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.

Authors:  Minoo Motahhar; Hadi Keyvanfar; Abdolhamid Shoushtari; Mohammad Hossein Fallah Mehrabadi; Gholamreza Nikbakht Brujeni
Journal:  Virus Genes       Date:  2022-09-13       Impact factor: 2.198

Review 4.  Certainty of success: three critical parameters in coronavirus vaccine development.

Authors:  David C Kaslow
Journal:  NPJ Vaccines       Date:  2020-05-25       Impact factor: 7.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.